Jeffrey Chamberlain, PhD
University of Washington
Dr. Jeffrey Chamberlain is a geneticist with expertise in the muscular dystrophies, and is currently a professor of neurology, medicine and biochemistry at the University of Washington School of Medicine, director of the Wellstone Muscular Dystrophy Specialized Research Center, and the McCaw Endowed Chair in Muscular Dystrophy. His research focuses on understanding mechanisms leading to, and developing treatments for, the muscular dystrophies with a focus on gene therapy. The Chamberlain lab invented ‘micro-dystrophin’ and discovered that some serotypes of AAV can be used for systemic gene delivery to muscle.
NOTE: If no session is listed above, this individual is a Chair or Co-chair of a session(s). Please see the individual session listings found in the Program for a full list of session participants.